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Background/Introduction
The St. Jude Medical Trifecta aortic supra-annular bio-
prosthesis is regarded as the next generation in pericar-
dial stented tissue valves. The unique design of tissue
leaflets attached to the exterior of the valve stent provides
unrivalled in-vivo mean gradients and haemodynamics.
Aims/Objectives
The aim of this prospective study was to evaluate mid-
term left ventricular (LV) mass regression following
implantation for aortic stenosis.
Method
One hundred and seventy two consecutive patients
undergoing aortic valve replacement using the St. Jude
Medical Trifecta valve at a single UK centre over a
48-month period were included in this study. Patients
undergoing concomitant cardiac procedures were
included. All implanted valves were 19, 21, 23, 25, 27 &
29 mm in size. Patients underwent both pre-operative
and post-operative transthoracic echocardiography.
Two-dimensional measurements of the left ventricle were
used to calculate LV mass using the Devereux equation.
Results
30 patients had the adequate 2-dimensional left ventricular
measurements recorded to calculate both pre- and post-
operative left ventricular mass. Valve Sizes were 21 mm
(n = 7), 23 mm (n = 15), 25 mm (n = 6) and 27 mm
(n = 2). Overall absolute left ventricular mass regression
was 18.1% ± 23.8%. Mean preoperative LV mass was 247.8g
± 102.5 g and mean postoperative LV mass was 200.7 ±
74.1g. Regression of LV Mass Index was -30.66 g/m2.
Discussion/Conclusion
Utilising available 2-D Measurements in this group we
observe regression of LV mass & LV Mass Index post
aortic valve replacement with the Trifecta bioprosthetic
valve. However, further consistent 2-D measurements are
required across the cohort to establish this relationship.
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